Stay updated on Durvalumab Combo in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Lung Cancer Clinical Trial page
- Check7 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check14 days agoChange DetectedA banner announces updates and FAQs about NIH’s terminology transition from “artificial intelligence” to “super intelligence.”SummaryDifference0.5%

- Check21 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check28 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov version as v3.7.1 instead of v3.7.0; the study record content is unchanged.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision entry v3.7.0 is added to the record history and the older revision v3.6.6 is removed from the list, updating the page's version history.SummaryDifference0.1%

- Check56 days agoChange DetectedA new history entry is added for version 34 dated 2026-08-18 and a Study Status update appears on 2026-09-11. An older 2026-05-01 entry was removed, reflecting an updated history of the study record.SummaryDifference0.3%

Stay in the know with updates to Durvalumab Combo in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Lung Cancer Clinical Trial page.